IDEAYA Biosciences, Inc.

Developing precision oncology therapies for molecularly defined cancers, led by darovasertib in uveal melanoma.

Back to company catalog

Precision oncology · Targeted small molecules and ADCs · Registrational Phase 2/3

Compare report options